AI agents can help businesses answer queries, process refunds and support customers, but the CMA says businesses remain responsible for what AI agents do.
Why Medicines Supply Chain Pressure Increases Distribution Planning Risk
UK medicines supply disruption highlights why specialist medicines wholesale and distribution planning is critical for GDP and WDA(H) operations.
Why Supplier Checks Matter in Medicines Wholesale
MHRA seizures show why medicines wholesale businesses need strong supplier checks, GDP controls and compliance route reviews before moving forward.
Medicine Supply Risks and GDP Compliance: What Businesses Should Check
New UK supply chain warnings show why medicines wholesalers need early warning systems, GDP controls and clear escalation processes.
New MHRA Licence Updates Show Why WDA(H) Readiness Matters
MHRA’s latest licence update shows ongoing medicines wholesale activity. Learn why WDA(H) readiness, GDP systems and RP oversight matter before market entry.
Faster Medicines Access and GDP Readiness: What Businesses Should Check
MHRA performance updates show faster medicines access in the UK. Learn why GDP readiness, WDA(H) planning and distribution controls matter.
Why Medicine Labelling Controls Matter for GDP Compliance
Recent MHRA updates show why medicine wholesalers need strong labelling, PIL, documentation and GDP quality controls.
Medicine Shortages: Why GDP Escalation Processes Matter
New DHSC medicine supply guidance shows why wholesalers need clear GDP escalation, documentation and communication processes.
Illegal Medicines Network Shows Why GDP Controls Matter
An MHRA illegal medicines case shows why storage, packaging, distribution routes, GDP controls and WDA(H) readiness matter.
Why Stability Failures Matter for GDP Compliance
A recent MHRA recall shows why medicines wholesalers need strong storage, transport, quarantine and GDP quality controls.
